measuregroup/AID1801254

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID46517470_AID1801254_PMID_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID254816975_AID1801254_PMID_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID46517470_AID1801254_PMID_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID254816976_AID1801254_PMID_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID254816975_AID1801254_PMID_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID254816976_AID1801254_PMID_VALUE6
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ92731 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP03372
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/BindingDB
title	Inhibition Assay from US Patent US9040509: \"Method of treating human skin and a skin care composition for use in such a method\"
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID46517470 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID254816976 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID254816975
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1801254

Total number of triples: 15.